We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UFI icon
2376
UNIFI
UFI
$127M
$110K ﹤0.01%
4,765
GNTY
2377
DELISTED
Guaranty Bancshares
GNTY
$109K ﹤0.01%
2,906
ATRO icon
2378
Astronics
ATRO
$4.34B
$109K ﹤0.01%
10,882
+7,458
+218% +$78.3K
SPFI icon
2379
South Plains Financial
SPFI
$858M
$108K ﹤0.01%
3,888
COOK icon
2380
Traeger
COOK
$172M
$108K ﹤0.01%
178
AERI
2381
DELISTED
Aerie Pharmaceuticals
AERI
$107K ﹤0.01%
15,265
NESR
2382
National Energy Services Reunited Corp
NESR
$3.51B
$107K ﹤0.01%
11,331
APPH
2383
DELISTED
AppHarvest, Inc. Common Stock
APPH
$107K ﹤0.01%
27,468
INTA icon
2384
Intapp
INTA
$3.05B
$107K ﹤0.01%
4,245
BATRA icon
2385
Atlanta Braves Holdings Series A
BATRA
$3.63B
$107K ﹤0.01%
3,713
GNK icon
2386
Genco Shipping & Trading
GNK
$1.1B
$106K ﹤0.01%
6,645
-5,334
-45% -$86.6K
CTMX icon
2387
CytomX Therapeutics
CTMX
$760M
$106K ﹤0.01%
24,446
+14,566
+147% +$85.3K
CTKB icon
2388
Cytek Biosciences
CTKB
$621M
$105K ﹤0.01%
6,449
HT
2389
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$105K ﹤0.01%
11,477
+7,549
+192% +$71.2K
HBMD
2390
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$105K ﹤0.01%
4,816
PVBC
2391
DELISTED
Provident Bancorp
PVBC
$105K ﹤0.01%
5,626
JANX icon
2392
Janux Therapeutics
JANX
$1.02B
$105K ﹤0.01%
5,302
HBIO icon
2393
Harvard Bioscience
HBIO
$28.1M
$105K ﹤0.01%
1,483
OSW icon
2394
OneSpaWorld
OSW
$2.7B
$104K ﹤0.01%
10,376
-8,539
-45% -$90.7K
AMRX icon
2395
Amneal Pharmaceuticals
AMRX
$6.15B
$104K ﹤0.01%
21,645
-18,760
-46% -$93.5K
RPT
2396
Rithm Property Trust
RPT
$99.9M
$103K ﹤0.01%
1,310
ASXC
2397
DELISTED
Asensus Surgical, Inc.
ASXC
$103K ﹤0.01%
92,945
+45,818
+97% +$70.8K
ALTG icon
2398
Alta Equipment Group
ALTG
$254M
$103K ﹤0.01%
7,040
CVM icon
2399
CEL-SCI Corp
CVM
$25.9M
$103K ﹤0.01%
483
CCRD
2400
DELISTED
CoreCard
CCRD
$102K ﹤0.01%
2,617

Similar funds

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.